Evidence map›Paper›PMID 38791936›Full record

ArticleCancers2024

What Is a Sarcoma 'Specialist Center'? Multidisciplinary Research Finds an Answer.

Roger Wilson, Denise Reinke, Gerard van Oortmerssen, Ornella Gonzato, Gabriele Ott, Chandrajit P Raut, B Ashleigh Guadagnolo, Rick L M Haas, Jonathan Trent, Robin Jones and 5 more

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Roger WilsonSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.ORCID 0000-0002-6043-7306
Denise ReinkeDivision of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-8662-7060
Gerard van OortmerssenSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.ORCID 0000-0002-0661-0833
Ornella GonzatoFondazione Paola Gonzato-Rete Sarcoma ETS, 33100 Udine, Italy.ORCID 0000-0002-6541-1228
Gabriele OttSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.
Chandrajit P RautDivision of Surgical Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
B Ashleigh GuadagnoloDivision of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Rick L M HaasNetherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0003-4834-4331
Jonathan TrentDepartment of Hematology Oncology, Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.ORCID 0000-0001-6169-5238
Robin JonesSarcoma Unit, Institute of Cancer Research, Royal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0003-4173-3844
Lauren PretoriusCampaigning for Cancer, Randburg 2196, South Africa.
Brandi FelserSarcoma Foundation of America, Washington, DC 20036, USA.
Mandy BassonSock it to Sarcoma, Perth 6000, Australia.
Kathrin SchusterSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.
Bernd KasperMannheim University Medical Center, University of Heidelberg, 68167 Mannheim, Germany.ORCID 0000-0001-8425-8356

Funding

PROJECT 3: Applying Liquid Biopsy Technologies to Detect Clinical Response and Mechanisms of Resistance in the Treatment of LMSP50CA272170 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JUDY E. GARBER · 2022 to 2026
$13.3M
NCI NIH HHS P50 CA272170
6 · The paper itself

Abstract

The management of sarcomas in specialist centers delivers significant benefits. In much of the world, specialists are not available, and the development of expertise is identified as a major need. However, the terms 'specialist' or 'expert' center are rarely defined. Our objective is to offer a definition for patient advocates and a tool for healthcare providers to underpin improving the care of people with sarcoma. SPAGN developed a discussion paper for a workshop at the SPAGN 2023 Conference, attended by 75 delegates. A presentation to the Connective Tissue Oncology Society (CTOS) and further discussion led to this paper. Core Principles were identified that underlie specialist sarcoma care. The primary Principle is the multi-disciplinary team discussing every patient, at first diagnosis and during treatment. Principles for optimal sarcoma management include accurate diagnosis followed by safe, high-quality treatment, with curative intent. These Principles are supplemented by Features describing areas of healthcare, professional involvement, and service provision and identifying further research and development needs. These allow for variations because of national or local policies and budgets. We propose the term 'Sarcoma Intelligent Specialist Network' to recognize expertise wherever it is found in the world. This provides a base for further discussion and local refinement.

Indexed as

clinical expertiseexpert centerpatient advocacysarcomaspecialist center

Identifiers

PMID38791936
PMCPMC11119625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.